Plain-English translation of NCT07579650 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a nerve-numbing injection called a serratus posterior superior intercostal plane block, designed to reduce pain after mastectomy (breast cancer surgery) and lymph node removal. Half of the participants will receive the actual numbing medication, and half will receive a placebo (saltwater) injection that looks identical. Everyone will also receive standard pain management during and after surgery.
Pain after breast surgery can be severe and lead to overuse of opioid medications, which carry risks of side effects and addiction. Researchers want to know if this nerve-numbing injection can safely reduce that pain as part of a comprehensive pain management plan.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the nerve-numbing injection or a placebo injection before your scheduled mastectomy surgery. Both injections are given under ultrasound guidance while you're under general anesthesia, so you won't feel anything. After surgery, the study team will ask you to rate your pain at regular intervals using a simple pain scale. You'll receive all standard surgical care and pain medications, and the study will track how much pain medication you need and how well you recover over time.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
Turkey (Türkiye)